IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Speciality Medicines Ltd.
Issue Open Date 20-Mar-26  
Issue Closing Date 24-Mar-26  
Application Money 100  
Allotment Money  
Price Band 117 - 124  
Minimium Application No. 2000  
Issue Size (Shares) 2350000  
Market Lot 1.00  
Objective
1. Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje: Manda, Tal. Umargam, Dist. Valsad, Gujarat;2. Product Registration in International Markets and Product Development for sale in international markets.3. Funding for Marketing and Promotional Activities.4. To Meet Working Capital Requirements; and5. General Corporate Purpose.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1239000   2194000   1.77  
Qualified Institutional Buyers   21000   2021000   96.24  
Retail Individual Investors   1090000   922000   0.85  
Business Description
Our company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. Having cultivated strong a
more...
Promoter's Holding
Total Share Capital   4035500  
Offered to Public   2350000  
Promoter's Holding (Pre-Issue)   62.16  
Promoter's Holding (Post-Issue)   43.43  
Address
913
One World West
S. No. 396
F P 119
Village- Vejalpur
Ahmedabad ,
Gujarat ,
380051
Phone:
Email: investors.grievances@specialitymedicine.com
Website: www.specialitymedicine.com
Registrar
Skyline Financial Services Pvt Ltd
D-153/A
1st Floor
Okhla Industrial Area
Phase - I
New Delhi
Listed at
BSE
Lead Manager
Unistone Capital Pvt Ltd.
Promoters
Parth Goyani
Sumit Goyani
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.